Background:
Cervical cancer is the second common cancer and the third reason of mortality among women in the world which is often occurred in third and fifth decades of their life. Cervical tumor recurrence observed in 30% of the patients and the 5-years survival rate of cervical cancer is about %50. The development of a rapid and non-invasive method for treatment response evaluation is one of the most challenges in cancer treatment management.Diffusion-weighted magnetic resonance imaging (DW-MRI) is a contrast agent free imaging technique thatis widely used for oncology studies.